The optimized use of gas chromatography-mass spectrometry and high performance liquid chromatography to analyse the serum bile acids of patients with metabolic cholestasis and peroxisomal disorders

Eur J Clin Chem Clin Biochem. 1997 Dec;35(12):919-22. doi: 10.1515/cclm.1997.35.12.919.

Abstract

We have measured the bile acids in human serum as methyl ester-trimethylsilyl ethers by gas chromatography-mass spectrometry (GC-MS) using an electron ionization procedure. The overall method was validated and the detection limit (0.4 mumol/l), linearity (2-30 mumol/l), intra-day and inter-day precision, accuracy and recovery (96.2% for nor-23-deoxycholic acid as internal standard) were measured. Serum C24-bile acids profiles from 43 cholestatic patients were measured by GC-MS and by HPLC. The results obtained with the two methods were well correlated and the criteria for selecting either HPLC or GC-MS identified. The serum C24- and C27-bile acids and C29 dicarboxylic bile acid profiles for patients with generalized peroxisomal deficiencies, like Zellweger syndrome (n = 5), neonatal adrenoleukodystrophy (n = 1), infantile Refsum disease (n = 2) and from a single peroxisomal deficiency (n = 1) were also measured by GC-MS.

MeSH terms

  • Adrenoleukodystrophy / physiopathology
  • Bile Acids and Salts / blood*
  • Cholestasis / physiopathology*
  • Chromatography, High Pressure Liquid / methods
  • Gas Chromatography-Mass Spectrometry / methods
  • Humans
  • Peroxisomal Disorders / physiopathology*
  • Refsum Disease / physiopathology
  • Regression Analysis
  • Reproducibility of Results
  • Zellweger Syndrome / physiopathology

Substances

  • Bile Acids and Salts